Lecture notes from Imperial College London, Medical Biosciences BSc, 2nd year, Cancer Biology (CBIO) module
learning outcomes:
- Define cancer therapeutic resistance
- Explain some of the different mechanisms of drug resistance
- Describe how cancer stem cells and epigenetic changes can giv...
Resistance, biomarkers, perso treatment
Introduction
- secondary mutation restores the function of BRCA1/BRCA2, resulting in resistance to PARPi:
Therapy resistance in cancer
- resistance can occur via genetic & epigenetic changes in cancer cells/ tumour microenvironment
(ex: increased matrix stiffness in liver cancers) 1) changes within cancer cells
give rise to
2) CSCs
resistance
- overcome resistance 3) epigenetic changes
=> alternative drug working via ≠ mechanisms
=> design drugs that specifically target this resistance
=> combination of therapies to target ≠ aspects of the tumour
=> personalised treatment
Drug resistance in cancer
- diagnosis (1st) = identifying the problem and giving it a name
- prognosis (2nd) = prediction of the course of the disease, treatments and results
=> poor for patients w/ metastatic cancer: 90% of chemo failure are related to drug resistance
- pharamacodynamics (PD) = how a drug affects the organism
- pharmacokinetics (PK) = how the organism affects the drug
, - drug absorbed - distributed => taken inside the cancer cell (drug influx) + activated to kill cells
=> drug efflux & metabolised - eliminated for patient safety
limit amount of drug reaching tumour
- drug activity also limited by
=> poor influx/ excessive efflux
=> drug inactivation/ lack of activation
=> alterations in drug target
=> activation of adaptive prosurvival responses
=> lack of cell death due to dysfunctional apoptosis
Mechanisms of drug resistance
- decreased uptake (influx)
=> methotrexate (toxic folic analogue): mutation of one/ both folate transporters to enter cells
=> nucleoside analogues: mutation of specific nucleoside transporters
=> cisplatin (chemotherapy): reduction in plasma membrane receptors, transporters & endocytosis
- increased drug efflux
=> P-glycoprotein (Pgp): ATP binding protein pump => pumps foreign substances out of cells
=> overexpression associated w/ resistance (doxorubicin, taxanes, vinca alkaloids)
=> inhibition of Pgp with verapamil can reverse drug resistance
- altered drug metabolism to increase detoxification
=> glutathione (GSH): antioxidant that protects the cells
=> conjugates to platinum chemo drugs & modif them to substrates for ABC transporters
(efflux)
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying this summary from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller lisaribau. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy this summary for R187,59. You're not tied to anything after your purchase.
